{"result": "(\"entity\"<|>BORNSTEIN SR<|>PERSON<|>Bornstein SR is an author of the Endocrine Society Clinical Practice Guideline on the diagnosis and treatment of primary adrenal insufficiency.)\n##\n(\"entity\"<|>ALLOLIO B<|>PERSON<|>Allolio B is an author of the Endocrine Society Clinical Practice Guideline on the diagnosis and treatment of primary adrenal insufficiency.)\n##\n(\"entity\"<|>ARLT W<|>PERSON<|>Arlt W is an author of the Endocrine Society Clinical Practice Guideline on the diagnosis and treatment of primary adrenal insufficiency.)\n##\n(\"entity\"<|>BARTHEL A<|>PERSON<|>Barthel A is an author of the Endocrine Society Clinical Practice Guideline on the diagnosis and treatment of primary adrenal insufficiency.)\n##\n(\"entity\"<|>DON-WAUCHOPE A<|>PERSON<|>Don-Wauchope A is an author of the Endocrine Society Clinical Practice Guideline on the diagnosis and treatment of primary adrenal insufficiency.)\n##\n(\"entity\"<|>HAMMER GD<|>PERSON<|>Hammer GD is an author of the Endocrine Society Clinical Practice Guideline on the diagnosis and treatment of primary adrenal insufficiency.)\n##\n(\"entity\"<|>DE MIGUEL NOVOA P<|>PERSON<|>De Miguel Novoa P is an author of the manual on primary adrenal insufficiency.)\n##\n(\"entity\"<|>STEWART PM<|>PERSON<|>Stewart PM is an author of the Williams Textbook of Endocrinology.)\n##\n(\"entity\"<|>NEWELL-PRICE JDC<|>PERSON<|>Newell-Price JDC is an author of the Williams Textbook of Endocrinology.)\n##\n(\"entity\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>ORGANIZATION<|>Harrison Principios de Medicina Interna is a medical textbook that includes information on adrenal disorders.)\n##\n(\"entity\"<|>UPTODATE<|>ORGANIZATION<|>UpToDate is a clinical decision support resource that provides information on the diagnosis of primary aldosteronism.)\n##\n(\"entity\"<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>ORGANIZATION<|>Manual de Endocrinología y Nutrición is a resource that discusses primary aldosteronism and adrenal insufficiency.)\n##\n(\"entity\"<|>INSUFICIENCIA SUPRARRENAL<|>EVENT<|>Insuficiencia suprarrenal refers to adrenal insufficiency, a medical condition discussed in the guidelines and manuals.)\n##\n(\"relationship\"<|>BORNSTEIN SR<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Bornstein SR contributed to the Endocrine Society Clinical Practice Guideline which is referenced in Harrison Principios de Medicina Interna<|>5)\n##\n(\"relationship\"<|>ALLOLIO B<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Allolio B contributed to the Endocrine Society Clinical Practice Guideline which is referenced in Harrison Principios de Medicina Interna<|>5)\n##\n(\"relationship\"<|>ARLT W<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Arlt W contributed to the Endocrine Society Clinical Practice Guideline which is referenced in Harrison Principios de Medicina Interna<|>5)\n##\n(\"relationship\"<|>BARTHEL A<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Barthel A contributed to the Endocrine Society Clinical Practice Guideline which is referenced in Harrison Principios de Medicina Interna<|>5)\n##\n(\"relationship\"<|>DON-WAUCHOPE A<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Don-Wauchope A contributed to the Endocrine Society Clinical Practice Guideline which is referenced in Harrison Principios de Medicina Interna<|>5)\n##\n(\"relationship\"<|>HAMMER GD<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Hammer GD contributed to the Endocrine Society Clinical Practice Guideline which is referenced in Harrison Principios de Medicina Interna<|>5)\n##\n(\"relationship\"<|>DE MIGUEL NOVOA P<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>De Miguel Novoa P authored a manual that discusses primary adrenal insufficiency<|>7)\n##\n(\"relationship\"<|>STEWART PM<|>UPTODATE<|>Stewart PM authored a textbook that is referenced in UpToDate for information on primary aldosteronism<|>5)\n##\n(\"relationship\"<|>NEWELL-PRICE JDC<|>UPTODATE<|>Newell-Price JDC authored a textbook that is referenced in UpToDate for information on primary aldosteronism<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: emia no\nes habitual en el paciente con insuficiencia suprarrenal de origen central, tampoco estaría\njustificada la presencia de hipopotasemia.\n\nLa angiotensina II es un estímulo clave para la secreción de aldosterona, y un daño o blo-\nqueo del sistema renina-angiotensina puede dar lugar a déficit de mineralocorticoide. El\ncuadro clínico más habitual asocia hiperpotasemia, acidosis y un deterioro entre leve y\nmoderado de la función renal.\n\nPor lo tanto, ni el seudohipoaldosteronismo, ni la insuficiencia suprarrenal secundaria ni el\nhipoaldosteronismo hiporreninémico justifican la necesidad de unos aportes suplementa-\nrios de potasio.\n\nReferencias:\n- Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. Diagnosis and treatment of primary adrenal\n  insufficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:364-89.\n- De Miguel Novoa P. Insuficiencia adrenal primaria. Manual de Endocrinología y Nutrición. Disponible en: https://manual.seen.es\n  (última modificación: 25 de noviembre de 2015).\n- Stewart PM, Newell-Price JDC. The adrenal cortex. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook\n  of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 490-555.\n---\n# SUPRARRENALES\n\n## 19. En un paciente hipertenso con actividad de renina plasmática (ARP) de 0,1 ng/ml/h (valores normales de 0,2 a 3,3 ng/ml/h), con aldosterona de 3 ng/dl (valores normales 4-31 ng/dl), y ratio aldosterona/ARP de 30, puede decirse que:\n\nA. La secreción de aldosterona es inadecuada.\nB. El diagnóstico de hiperaldosteronismo secundario es más plausible, por lo que se deben buscar las causas del mismo.\nC. No son precisos test confirmatorios de hiperaldosteronismo primario con un ratio aldosterona/ARP mayor a 20.\nD. El paciente se podría beneficiar, antes de realizar test confirmatorios de hiperaldosteronismo primario, de tratamiento con espironolactona.\n\n### COMENTARIO\n\nLa prueba de cribado recomendada para el estudio del paciente con sospecha de hiperaldosteronismo primario es la relación entre la aldosterona plasmática y la actividad de renina plasmática (ALD/ARP). El valor de corte más aceptado para la relación ALD/ARP es 30 cuando la aldosterona se presenta como nanogramos por decilitro y la actividad de renina plasmática como nanogramos por mililitro por hora.\n\nUna limitación de la relación ALD/ARP es que en presencia de valores muy bajos de ARP (p. ej, 0,1 ng/ml/h), la relación ALD/ARP puede ser superior a 30 aunque los valores de aldosterona sean bajos y no sugerentes de hiperaldosteronismo (p. ej., 4 ng/dl).\n\nExisten otras causas diferentes de la presencia de hiperaldosteronismo primario que deben ser tenidas en cuenta al estudiar al paciente con hipertensión e hipopotasemia. Entre ellas destacan, por frecuencia, la toma de diuréticos, la enfermedad renovascular (la ARP estará elevada), los hipermineralocorticismos no dependientes de aldosterona (en ellos, renina y aldosterona estarán suprimidos) y los hiperaldosteronismos secundarios (en ellos, renina y aldosterona estarán elevados).\n\nReferencias:\n- Arlt W. Trastornos de la corteza suprarrenal. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, eds. Harrison Principios de Medicina Interna. 19.ª edición en español. México DF: Mc Graw Hill; 2016. p. 2309-29.\n- Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889-916.\n- Lahera Vargas M. Hiperaldosteronismo primario. Manual de Endocrinología y Nutrición. Disponible en: https://manual.seen.es (última modificación: 25 de noviembre de 2015).\n- Young WF, Jr. Diagnosis of primary aldosteronism. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com. Literature review current through: Apr. 2019.\n- Young WF, Jr. Endocrine Hypertension. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook of Endocrin\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}